CD70 and Miyoshi myopathy: A full-length CD27 extracellular domain (ECD)-based CAR against CD70 did not show any signs of fratricide and exhibited robust efficacy with minimal toxicity in vitro against MM, making CD70 a promising candidate target for next-line treatment [115].